FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jean-Paul Ortonne

Research Profile

Disorders

Living Beings

Mouse

Concepts & Ideas

Anatomy

Chemicals & Drugs

Procedures

Double-Blind Method

Phenomena

Fluorescent Antibody Technique

Co-author Network

Publications

TOP 3
Jean-Paul Ortonne; Carle Paul; V Marino; E Berardesca; Y Brault; G Gallo; J M Germain
A 24-week randomized clinical trial investigating the efficacy and safety of two doses of etanercept in nail psoriasis.
Christine Chiavérini; Geneviève Guest; Hee-Young Kang; Jean-Philippe Lacour; Patrick Niaudet; Philippe Bahadoran; Robert Ballotti; Etienne Berard; Mathilde Cailliez; Laura Sillard; Jean-Paul Ortonne
In vivo reflectance confocal microscopy of the skin: a noninvasive means of assessing body cystine accumulation in infantile cystinosis.
Y Harmelin; J-P Lacour; Jean-Paul Ortonne; Philippe Bahadoran; Nathalie Cardot-Leccia; Thierry Passeron
Localized depigmentation on genital melanosis: a clue for the understanding of vitiligo.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jean-Paul Ortonne (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jean-Paul Ortonne; Carle Paul; V Marino; E Berardesca; Y Brault; G Gallo; J M Germain
A 24-week randomized clinical trial investigating the efficacy and safety of two doses of etanercept in nail psoriasis.
The British journal of dermatology 2013;168(5):1080-7.
2013: Christine Chiavérini; Geneviève Guest; Hee-Young Kang; Jean-Philippe Lacour; Patrick Niaudet; Philippe Bahadoran; Robert Ballotti; Etienne Berard; Mathilde Cailliez; Laura Sillard; Jean-Paul Ortonne
In vivo reflectance confocal microscopy of the skin: a noninvasive means of assessing body cystine accumulation in infantile cystinosis.
Journal of the American Academy of Dermatology 2013;68(4):e111-6.
2013: Y Harmelin; J-P Lacour; Jean-Paul Ortonne; Philippe Bahadoran; Nathalie Cardot-Leccia; Thierry Passeron
Localized depigmentation on genital melanosis: a clue for the understanding of vitiligo.
The British journal of dermatology 2013;168(3):663-4.
2013: Pearl E Grimes; Iltefat Hamzavi; Mark Lebwohl; Jean-Paul Ortonne; Henry W Lim
The efficacy of afamelanotide and narrowband UV-B phototherapy for repigmentation of vitiligo.
JAMA dermatology (Chicago, Ill.) 2013;149(1):68-73.
2012: Jean-Paul Ortonne
Normal and abnormal skin color.
Annales de dermatologie et de vénéréologie 2012;139 Suppl 4():S125-9.
2012: E Cuerda; R Linares; J L López Estebaranz; M A Palomar; Jean-Paul Ortonne
Hair removal home devices: are they safe?
Journal of the European Academy of Dermatology and Venereology : JEADV 2012;26(12):1584-5.
2012: D J Lee; J Lee; Jean-Paul Ortonne; K-C Park; J Ha; H Y Kang
Defective barrier function in melasma skin.
Journal of the European Academy of Dermatology and Venereology : JEADV 2012;26(12):1533-7.
2012: Thierry Passeron; Jean-Paul Ortonne
Activation of the unfolded protein response in vitiligo: the missing link?
The Journal of investigative dermatology 2012;132(11):2502-4.
2012: A Khemis; A C Coudert; O Dereure; Luc Duteil; Y Tillet; Jean-Paul Ortonne
Evaluation of the efficacy and safety of a CS20® protective barrier gel containing OGT compared with topical aciclovir and placebo on functional and objective symptoms of labial herpes recurrences: a randomized clinical trial.
Journal of the European Academy of Dermatology and Venereology : JEADV 2012;26(10):1240-6.
2012: Christine Chiaverini; Pierre Cochat; Enrica Flori; Eric Fontas; Michel Foulard; Geneviève Guest; Shosuke Ito; Patrick Niaudet; Jean-Paul Ortonne; Mauro Picardo; Laura Sillard; Kazumasa Wakamatsu; Etienne Berard; François-Xavier Bernard; Stefania Briganti; Mathilde Cailliez; Corinne Antignac; Robert Ballotti
Cystinosin is a melanosomal protein that regulates melanin synthesis.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2012;26(9):3779-89.
2012: Pierre-Antoine Gourraud; Caroline Le Gall; Jean-Paul Ortonne; François Aubin; Eve Puzenat; Carle Paul
Why statistics matter: limited inter-rater agreement prevents using the psoriasis area and severity index as a unique determinant of therapeutic decision in psoriasis.
The Journal of investigative dermatology 2012;132(9):2171-5.
2012: Michèle Verschoore; Vinod K Sharma; Somesh Gupta; Jean-Paul Ortonne
Determination of Melanin and Haemoglobin in the Skin of Idiopathic Cutaneous Hyperchromia of the Orbital region (ICHOR): A Study of Indian Patients.
Journal of cutaneous and aesthetic surgery 2012;5(3):176-82.
2012: Kim A Papp; Chris B Russell; Elizabeth H Z Thompson; Girish Aras; Gregory Kricorian; James G Krueger; Craig Leonardi; Juan Li; Alan Menter; Jean-Paul Ortonne; Scott Baumgartner
Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis.
The New England journal of medicine 2012;366(13):1181-9.
2012: D J Lee; Jean-Paul Ortonne; K-C Park; Hee Young Kang
Pendulous melanocytes: a characteristic feature of melasma and how it may occur.
The British journal of dermatology 2012;166(3):684-6.
2012: Laurent Misery; Jean-Paul Ortonne; Nora Rahhali; Marie Auges; Frédéric Cambazard; Vincent Durosier; Gérard Guillet; Gérard Lorette; Luc Thomas; C Taieb
PPAD: a tool for presumption of atopic dermatitis.
The Journal of dermatology 2012;39(2):151-5.
2011: Thierry Passeron; Coralie Ségalen; Antoine Thyss; Maryline Allegra; Robert Ballotti; Corine Bertolotto; Anne Deville; Damien Giacchero; Jean-Philippe Lacour; Jean-Paul Ortonne; Philippe Bahadoran
Signalling and chemosensitivity assays in melanoma: is mutated status a prerequisite for targeted therapy?
Experimental dermatology 2011;20(12):1030-2.
2011: Jean-Paul Ortonne
Chronic urticaria: a comparison of management guidelines.
Expert opinion on pharmacotherapy 2011;12(17):2683-93.
2011: Katerina Tsilika; Luc Duteil; Rosalind Hughes; Hee Young Kang; Abdallah Khemis; Jean Luc Levy; Jean-Paul Ortonne; Thierry Passeron; Philippe Bahadoran
A pilot study using reflectance confocal microscopy (RCM) in the assessment of a novel formulation for the treatment of melasma.
Journal of drugs in dermatology : JDD 2011;10(11):1260-4.
2011: Kristian Reich; Kristina Unnebrink; Martin Kaul; Richard G Langley; Jean-Paul Ortonne; Kim A Papp; Joaquin M Valdes
A 52-week trial comparing briakinumab with methotrexate in patients with psoriasis.
The New England journal of medicine 2011;365(17):1586-96.
2011: Nouran Erfan; Hee-Young Kang; Jean-Philippe Lacour; Jean-Paul Ortonne; Thierry Passeron; Nathalie Cardot-Leccia; Bérangère Chignon-Sicard; Philippe Bahadoran
Reflectance confocal microscopy for recurrent lentigo maligna.
Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 2011;37(10):1519-24.
2011: Thierry Passeron; Philippe Bahadoran; Eric Fontas; Hee Young Kang; Jean-Philippe Lacour; Jean-Paul Ortonne
Melasma treatment with pulsed-dye laser and triple combination cream: a prospective, randomized, single-blind, split-face study.
Archives of dermatology 2011;147(9):1106-8.
2011: Jean-Paul Ortonne; K Reich; P Sprøgel; S Chimenti; R Gniadecki; O Goldblum; H Kupper; Kristina Unnebrink; Diamant Thaçi
Efficacy and safety of adalimumab in patients with psoriasis previously treated with anti-tumour necrosis factor agents: subanalysis of BELIEVE.
Journal of the European Academy of Dermatology and Venereology : JEADV 2011;25(9):1012-20.
2011: Luigi Naldi; Nikhil Yawalkar; Andrzej Kaszuba; Jean-Paul Ortonne; Paolo Morelli; Stefano Rovati; Giuseppe Mautone
Efficacy and safety of the Betamethasone valerate 0.1% plaster in mild-to-moderate chronic plaque psoriasis: a randomized, parallel-group, active-controlled, phase III study.
American journal of clinical dermatology 2011;12(3):191-201.
2011: Christine Bangert; Bruce E Strober; Michael Cork; Jean-Paul Ortonne; Thomas Luger; Thomas Bieber; Adam Ferguson; Rupert C Ecker; Tamara Kopp; Sophia Weise-Riccardi; Achim Guettner; Georg Stingl
Clinical and cytological effects of pimecrolimus cream 1% after resolution of active atopic dermatitis lesions by topical corticosteroids: a randomized controlled trial.
Dermatology (Basel, Switzerland) 2011;222(1):36-48.
2011: Kim A Papp; J Crowley; Jean-Paul Ortonne; J Leu; M Okun; S R Gupta; Y Gu; Richard G B Langley
Adalimumab for moderate to severe chronic plaque psoriasis: efficacy and safety of retreatment and disease recurrence following withdrawal from therapy.
The British journal of dermatology 2011;164(2):434-41.
2011: Nina Fenouille; Guillaume ROBERT; Mélanie Tichet; Alexandre Puissant; Maeva Dufies; Stéphane Rocchi; Jean-Paul Ortonne; Marcel Deckert; Robert Ballotti; Sophie Tartare-Deckert
The p53/p21Cip1/ Waf1 pathway mediates the effects of SPARC on melanoma cell cycle progression.
Pigment cell & melanoma research 2011;24(1):219-32.
2011: Emeline Castela; Christine Lebrun-Frenay; Muriel Laffon; Fanny Rocher; Michael Cohen; Nathalie Cardot Leccia; Philippe Bahadoran; Jean-Philippe Lacour; Jean-Paul Ortonne; Thierry Passeron
Evolution of nevi during treatment with natalizumab: A prospective follow-up of patients treated with natalizumab for multiple sclerosis.
Archives of dermatology 2011;147(1):72-6.
2011: Amit G Pandya; Linda Hynan; Rafia Bhore; Fransell Copeland Riley; Ian L Guevara; Pearl Grimes; James J Nordlund; Marta Rendon; Susan Taylor; Ronald W Gottschalk; Nnenna G Agim; Jean-Paul Ortonne
Reliability assessment and validation of the Melasma Area and Severity Index (MASI) and a new modified MASI scoring method.
Journal of the American Academy of Dermatology 2011;64(1):78-83, 83.e1-2.
2010: Hee Young Kang; Jean-Paul Ortonne
What should be considered in treatment of melasma.
Annals of dermatology 2010;22(4):373-8.
2010: Rosalind Hughes; Jean-Philippe Lacour; Bernadette Baldin; Marc Reverte; Jean-Paul Ortonne; Thierry Passeron
Urticarial vasculitis secondary to H1N1 vaccination.
Acta dermato-venereologica 2010;90(6):651-2.
2010: Hee Young Kang; Florence le Duff; Thierry Passeron; Jean-Philippe Lacour; Jean-Paul Ortonne; Philippe Bahadoran
A noninvasive technique, reflectance confocal microscopy, for the characterization of melanocyte loss in untreated and treated vitiligo lesions.
Journal of the American Academy of Dermatology 2010;63(5):e97-100.
2010: Mona Ståhle; Nilgun Atakan; Wolf-Henning Boehncke; Sergio Chimenti; Esteban Daudén; Alberto Giannetti; Peter Hoeger; Pascal Joly; andreas katsabas; Knud Kragballe; Jo Lambert; Jean-Paul Ortonne; Joerg C Prinz; Lluís Puig; Marieke Seyger; Robert Strohal; Peter Van De Kerkhoff; Wolfram Sterry
Juvenile psoriasis and its clinical management: a European expert group consensus.
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2010;8(10):812-8.
2010: Jean-Paul Ortonne; Kirsten Lykke Noerrelund; Kim Papp; Lydia Van Herpe; Michael Sebastian; Enrique Herrera; Bhavesh Bodalia
Comparison of two different dose combinations of calcipotriol/hydrocortisone ointment used once daily for the treatment of psoriasis vulgaris on the face and body.
European journal of dermatology : EJD 2010;20(5):585-9.
2010: D Bouilly-Gauthier; C Jeannes; Y Maubert; Luc Duteil; Catherine Queille-Roussel; N Piccardi; C Montastier; P Manissier; G Piérard; Jean-Paul Ortonne
Clinical evidence of benefits of a dietary supplement containing probiotic and carotenoids on ultraviolet-induced skin damage.
The British journal of dermatology 2010;163(3):536-43.
2010: Richard G B Langley; Steven R Feldman; Chenglong Han; Brad Schenkel; Philippe Szapary; Ming-Chun Hsu; Jean-Paul Ortonne; Kenneth B Gordon; Alexa B Kimball
Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: Results from a randomized, double-blind, placebo-controlled phase III trial.
Journal of the American Academy of Dermatology 2010;63(3):457-65.
2010: Craig Leonardi; Bruce Strober; Alice B Gottlieb; Boni E Elewski; Jean-Paul Ortonne; Peter van de Kerkhof; Chiun-Fang Chiou; Meleana Dunn; Angelika Jahreis
Long-term safety and efficacy of etanercept in patients with psoriasis: an open-label study.
Journal of drugs in dermatology : JDD 2010;9(8):928-37.
2010: Hee Young Kang; Philippe Bahadoran; Itaru Suzuki; Didier Zugaj; Abdallah Khemis; Thierry Passeron; Philippe Andres; Jean-Paul Ortonne
In vivo reflectance confocal microscopy detects pigmentary changes in melasma at a cellular level resolution.
Experimental dermatology 2010;19(8):e228-33.
2010: F Le Duff; E Fontas; D Giacchero; L Sillard; J-P Lacour; Jean-Paul Ortonne; Thierry Passeron
308-nm excimer lamp vs. 308-nm excimer laser for treating vitiligo: a randomized study.
The British journal of dermatology 2010;163(1):188-92.
2010: Jean-Paul Ortonne; Girish Gupta; Nicolas Ortonne; Luc Duteil; Catherine Queille; Pascal Mallefet
Effectiveness of cross polarized light and fluorescence diagnosis for detection of sub-clinical and clinical actinic keratosis during imiquimod treatment.
Experimental dermatology 2010;19(7):641-7.
2010: E Ly; Nathalie Cardot-Leccia; Jean-Paul Ortonne; M Benchetrit; Jean-François Michiels; M Manfait; olivier piot
Histopathological characterization of primary cutaneous melanoma using infrared microimaging: a proof-of-concept study.
The British journal of dermatology 2010;162(6):1316-23.
2010: Janet L Roberts; Jean-Paul Ortonne; Jerry K L Tan; Eileen Jaracz; Ellen Frankel
The safety profile and sustained remission associated with response to multiple courses of intramuscular alefacept for treatment of chronic plaque psoriasis.
Journal of the American Academy of Dermatology 2010;62(6):968-78.
2010: Hee Young Kang; Philippe Bahadoran; Jean-Paul Ortonne
Reflectance confocal microscopy for pigmentary disorders.
Experimental dermatology 2010;19(3):233-9.
2010: Kristian Reich; Jean-Paul Ortonne; Urs Kerkmann; Yanxin Wang; Jean-Hilaire Saurat; Kim Papp; Richard Langley; Christopher E M Griffiths
Skin and nail responses after 1 year of infliximab therapy in patients with moderate-to-severe psoriasis: a retrospective analysis of the EXPRESS Trial.
Dermatology (Basel, Switzerland) 2010;221(2):172-8.
2010: Wolfram Sterry; Jean-Paul Ortonne; Bruce Kirkham; Olivier Brocq; Deborah Robertson; Ronald D Pedersen; Joanne Estojak; Charles T Molta; Bruce Freundlich
Comparison of two etanercept regimens for treatment of psoriasis and psoriatic arthritis: PRESTA randomised double blind multicentre trial.
BMJ (Clinical research ed.) 2010;340():c147.
2010: L Sillard; Thierry Passeron; Nathalie Cardot-Leccia; Christophe Perrin; Jean-Philippe Lacour; Jean-Paul Ortonne
[Efficacy of intravenous immunoglobulin in the treatment of scleromyxoedema].
Annales de dermatologie et de vénéréologie 2010;137(1):48-52.
2009: Jean-Paul Ortonne; A Taïeb; A D Ormerod; D Robertson; J Foehl; R Pedersen; C Molta; B Freundlich
Patients with moderate-to-severe psoriasis recapture clinical response during re-treatment with etanercept.
The British journal of dermatology 2009;161(5):1190-5.
2009: Jean-Paul Ortonne
[Normal and abnormal human skin color: from research to esthetics].
Annales de dermatologie et de vénéréologie 2009;136 Suppl 6():S252-6.
2009: V Del Marmol; Thomas Luger; Norbert J Neumann; Jean-Paul Ortonne
Public health issues arising from sale of illegal and potentially unsafe 'tanning chemicals'.
Pigment cell & melanoma research 2009;22(5):648.
2009: Sandrine Marchetti; Parvati Gamas; Nathalie Belhacène; Sebastien Grosso; Ludivine A Pradelli; Pascal Colosetti; Claus Johansen; Lars Iversen; Marcel Deckert; Fréderic Luciano; Paul Hofman; Nicolas Ortonne; Abdallah Khemis; Bernard Mari; Jean-Paul Ortonne; Jean-Ehrland Ricci; Patrick Auberger
The caspase-cleaved form of LYN mediates a psoriasis-like inflammatory syndrome in mice.
The EMBO journal 2009;28(16):2449-60.
2009: Jean-Paul Ortonne; C Ganslandt; J Tan; P Nordin; K Kragballe; S Segaert
Quality of life in patients with scalp psoriasis treated with calcipotriol/betamethasone dipropionate scalp formulation: a randomized controlled trial.
Journal of the European Academy of Dermatology and Venereology : JEADV 2009;23(8):919-26.
2009: Yann Cheli; Flavie Luciani; Mehdi Khaled; Laurent Beuret; Karine Bille; Pierre GOUNON; Jean-Paul Ortonne; Corine Bertolotto; Robert Ballotti
{alpha}MSH and Cyclic AMP elevating agents control melanosome pH through a protein kinase A-independent mechanism.
The Journal of biological chemistry 2009;284(28):18699-706.
2009: Thierry Passeron; Jean-Philippe Lacour; Jean-Paul Ortonne
Comparative treatment of extragenital lichen sclerosus with methylaminolevulinic Acid pulsed dye laser-mediated photodynamic therapy or pulsed dye laser alone.
Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 2009;35(5):878-80.
2009: Mark Lebwohl; Jean-Paul Ortonne; Philippe Andres; Philippe Briantais
Calcitriol ointment 3 microg/g is safe and effective over 52 weeks for the treatment of mild to moderate plaque psoriasis.
Cutis; cutaneous medicine for the practitioner 2009;83(4):205-12.
2009: Olivier Bailet; Nina Fenouille; Patricia Abbe; Guillaume ROBERT; Stéphane Rocchi; Nadège Gonthier; Christophe Denoyelle; Michel Ticchioni; Jean-Paul Ortonne; Robert Ballotti; Marcel Deckert; Sophie Tartare-Deckert
Spleen tyrosine kinase functions as a tumor suppressor in melanoma cells by inducing senescence-like growth arrest.
Cancer research 2009;69(7):2748-56.
2009: Emeline Castela; Pierre Thomas; Valérie Bronsard; Jean-Philippe Lacour; Jean-Paul Ortonne; Thierry Passeron
Blue pseudochromhidrosis secondary to topiramate treatment.
Acta dermato-venereologica 2009;89(5):538-9.
2009: Hee Young Kang; Laure Valerio; Philippe Bahadoran; Jean-Paul Ortonne
The role of topical retinoids in the treatment of pigmentary disorders: an evidence-based review.
American journal of clinical dermatology 2009;10(4):251-60.
2009: Thierry Passeron; Abdallah Khemis; Jean-Paul Ortonne
Pulsed dye laser-mediated photodynamic therapy for acne inversa is not successful: a pilot study on four cases.
The Journal of dermatological treatment 2009;20(5):297-8.
2008: Jean-Paul Ortonne
[What's new in dermatological treatments?].
Annales de dermatologie et de vénéréologie 2008;135 Suppl 7():S360-70.
2008: Pascal Del Giudice; Véronique Blanc-Amrane; Philippe Bahadoran; Eric Caumes; Pierre Marty; Mariléna Lazar; Christian Boissy; François Desruelles; Arezki Izri; Jean-Paul Ortonne; Evelyne Counillon; Olivier Chosidow; Pascal Delaunay
Pyemotes ventricosus dermatitis, southeastern France.
Emerging infectious diseases 2008;14(11):1759-61.
2008: Gregor Jemec; Cecilia Ganslandt; Jean-Paul Ortonne; Yves Poulin; A David Burden; Pablo de Unamuno; Berit Berne; Américo Figueiredo; Joar Austad
A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.
Journal of the American Academy of Dermatology 2008;59(3):455-63.
2008: Jean-Paul Ortonne
[What are the objectives of moderate to severe psoriasis treatment?].
Annales de dermatologie et de vénéréologie 2008;135 Suppl 5():S281-4.
2008: Rolf-Markus Szeimies; J Bichel; Jean-Paul Ortonne; E Stockfleth; J Lee; T-C Meng
A phase II dose-ranging study of topical resiquimod to treat actinic keratosis.
The British journal of dermatology 2008;159(1):205-10.
2008: Caroline Hilmi; Lionel Larribere; Sandy Giuliano; Karine Bille; Jean-Paul Ortonne; Robert Ballotti; Corine Bertolotto
IGF1 promotes resistance to apoptosis in melanoma cells through an increased expression of BCL2, BCL-X(L), and survivin.
The Journal of investigative dermatology 2008;128(6):1499-505.
2008: Christine Chiaverini; Laurent Beuret; Enrica Flori; Roser Busca; Patricia Abbe; Karine Bille; Philippe Bahadoran; Jean-Paul Ortonne; Corine Bertolotto; Robert Ballotti
Microphthalmia-associated transcription factor regulates RAB27A gene expression and controls melanosome transport.
The Journal of biological chemistry 2008;283(18):12635-42.
2008: Adèle C Green; Maria C Hughes; Torukiri I Ibiebele; Gail M Williams; Jolieke C van der Pols; Jean-Paul Ortonne
Antioxidant supplementation and risk of skin cancers.
The Journal of nutrition 2008;138(5):978; author reply 979.
2008: C Hilmi; Lionel Larribere; M Deckert; S Rocchi; S Giuliano; Karine Bille; Jean-Paul Ortonne; Robert Ballotti; Corine Bertolotto
Involvement of FKHRL1 in melanoma cell survival and death.
Pigment cell & melanoma research 2008;21(2):139-46.
2008: Jean-Paul Ortonne; Donald L Bissett
Latest insights into skin hyperpigmentation.
The journal of investigative dermatology. Symposium proceedings / the Society for Investigative Dermatology, Inc. [and] European Society for Dermatological Research 2008;13(1):10-4.
2008: Jean-Paul Ortonne
[Normal and abnormal human skin colour: from research to aesthetics].
Annales de dermatologie et de vénéréologie 2008;135 Suppl 3():S153-6.
2008: Kristian Reich; Christopher E M Griffiths; Jonathan Barker; Sergio Chimenti; Esteban Daudén; Alberto Giannetti; Robert Gniadecki; andreas katsabas; Richard Langley; Ulrich Mrowietz; Alexandra Ogilvie; Jean-Paul Ortonne; Norbert Reider; Jean-Hilaire Saurat
Recommendations for the long-term treatment of psoriasis with infliximab: a dermatology expert group consensus.
Dermatology (Basel, Switzerland) 2008;217(3):268-75.
2008: Kristina Dahlman-Ghozlan; Jean-Paul Ortonne; Philippe Bahadoran; Anne Spadafora; Eija Stephansson
Low-dose oral methotrexate induces apoptosis of tissue eosinophils in bullous pemphigoid.
Acta dermato-venereologica 2008;88(3):219-22.
2007: M Vatve; Jean-Paul Ortonne; M A Birch-Machin; G Gupta
Management of field change in actinic keratosis.
The British journal of dermatology 2007;157 Suppl 2():21-4.
2007: Dédée F Murrell; S Calvieri; Jean-Paul Ortonne; Vincent C Ho; S Weise-Riccardi; N Barbier; Carle Paul
A randomized controlled trial of pimecrolimus cream 1% in adolescents and adults with head and neck atopic dermatitis and intolerant of, or dependent on, topical corticosteroids.
The British journal of dermatology 2007;157(5):954-9.
2007: Francesca Prignano; Jean-Paul Ortonne; Gionata Buggiani; Torello Lotti
Therapeutical approaches in melasma.
Dermatologic clinics 2007;25(3):337-42, viii.
2007: A Khemis; A Kaiafa; Catherine Queille-Roussel; Luc Duteil; Jean-Paul Ortonne
Evaluation of efficacy and safety of rucinol serum in patients with melasma: a randomized controlled trial.
The British journal of dermatology 2007;156(5):997-1004.
2007: Thierry Passeron; Jean-Philippe Lacour; Eric Fontas; Jean-Paul Ortonne
Treatment of oral erosive lichen planus with 1% pimecrolimus cream: a double-blind, randomized, prospective trial with measurement of pimecrolimus levels in the blood.
Archives of dermatology 2007;143(4):472-6.
2007: Thierry Passeron; K Angeli; N Cardot-Leccia; C Perrin; Jean-Philippe Lacour; Jean-Paul Ortonne
[Treatment of mycosis fungoides by 308 nm excimer laser: a clinical and histological study in 10 patients].
Annales de dermatologie et de vénéréologie 2007;134(3 Pt 1):225-31.
2007: Thierry Passeron; K Sebban; Frédéric Mantoux; Eric Fontas; Jean-Philippe Lacour; Jean-Paul Ortonne
[595 nm pulse dye laser therapy for viral warts: a single-blind randomized comparative study versus placebo].
Annales de dermatologie et de vénéréologie 2007;134(2):135-9.
2007: Cedric Gaggioli; Guillaume ROBERT; Corine Bertolotto; Olivier Bailet; Patricia Abbe; Anne Spadafora; Philippe Bahadoran; Jean-Paul Ortonne; Véronique Baron; Robert Ballotti; Sophie Tartare-Deckert
Tumor-derived fibronectin is involved in melanoma cell invasion and regulated by V600E B-Raf signaling pathway.
The Journal of investigative dermatology 2007;127(2):400-10.
2007: Sakari Reitamo; Jean-Paul Ortonne; Carsten Sand; Jan Bos; Frédéric Cambazard; Thomas Bieber; Christian Grønhøj-Larsen; Malcolm Rustin; Regina Fölster-Holst; Marie-Louise Schuttelaar
Long-term treatment with 0.1% tacrolimus ointment in adults with atopic dermatitis: results of a two-year, multicentre, non-comparative study.
Acta dermato-venereologica 2007;87(5):406-12.
2007: Jean-Paul Ortonne; Jean-Jacques Grob; Pascal Auquier; Isabelle Dreyfus
Efficacy and safety of desloratadine in adults with chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, multicenter trial.
American journal of clinical dermatology 2007;8(1):37-42.
2006: Jean-Paul Ortonne
Retinoid therapy of pigmentary disorders.
Dermatologic therapy 2006;19(5):280-8.
2006: J J Nordlund; Pearl E Grimes; Jean-Paul Ortonne
The safety of hydroquinone.
Journal of the European Academy of Dermatology and Venereology : JEADV 2006;20(7):781-7.
2006: Jean-Paul Ortonne; Catherine Queille-Roussel; Luc Duteil
3% diclofenac in 2.5% hyaluronic acid (Solaraze) does not induce photosensitivity or phototoxicity alone or in combination with sunscreens.
European journal of dermatology : EJD 2006;16(4):385-90.
2006: James Nordlund; Pearl Grimes; Jean-Paul Ortonne
The safety of hydroquinone.
Journal of cosmetic dermatology 2006;5(2):168-9.
2006: Kristian Reich; Frank O Nestle; Kim A Papp; Jean-Paul Ortonne; Y Wu; Mohan Bala; Robert Evans; Cynthia Guzzo; Shu Li; Lisa T Dooley; Christopher E M Griffiths
Improvement in quality of life with infliximab induction and maintenance therapy in patients with moderate-to-severe psoriasis: a randomized controlled trial.
The British journal of dermatology 2006;154(6):1161-8.
2006: James J Nordlund; Jean-Paul Ortonne; Tania Cestari; Pearl E Grimes; Henry Chan
Confusions about color: formulating a more precise lexicon for pigmentation, pigmentary disorders, and abnormalities of "chromatics".
Journal of the American Academy of Dermatology 2006;54(5 Suppl 2):S291-7.
2006: Jean-Paul Ortonne; Amit G Pandya; Harvey Lui; Doris Hexsel
Treatment of solar lentigines.
Journal of the American Academy of Dermatology 2006;54(5 Suppl 2):S262-71.
2006: Pearl E Grimes; James J Nordlund; Amit G Pandya; Susan Taylor; Marta Rendon; Jean-Paul Ortonne
Increasing our understanding of pigmentary disorders.
Journal of the American Academy of Dermatology 2006;54(5 Suppl 2):S255-61.
2006: Thierry Passeron; Jean-Philippe Lacour; Eric Fontas; Jean-Paul Ortonne
Prebiotics and synbiotics: two promising approaches for the treatment of atopic dermatitis in children above 2 years.
Allergy 2006;61(4):431-7.
2006: Alice B Gottlieb; Craig L Leonardi; Bernard S Goffe; Jean-Paul Ortonne; Peter C M van der Kerkhof; Ralph Zitnik; Arline Nakanishi; Angelika Jahreis
Etanercept monotherapy in patients with psoriasis: a summary of safety, based on an integrated multistudy database.
Journal of the American Academy of Dermatology 2006;54(3 Suppl 2):S92-100.
2006: Nima Ostovari; Thierry Passeron; Jean-Philippe Lacour; Jean-Paul Ortonne
Lack of efficacy of tacrolimus in the treatment of vitiligo in the absence of UV-B exposure.
Archives of dermatology 2006;142(2):252-3.
2006: Thierry Passeron; Jean-Paul Ortonne
What's new in hypochromy.
The Journal of dermatological treatment 2006;17(2):70-3.
2006: Jean-Paul Ortonne; P C M van de Kerkhof; Jörg C Prinz; Thomas Bieber; Morad Lahfa; Andris Rubins; Gottfried Wozel; Gérard Lorette
0.3% Tacrolimus gel and 0.5% Tacrolimus cream show efficacy in mild to moderate plaque psoriasis: Results of a randomized, open-label, observer-blinded study.
Acta dermato-venereologica 2006;86(1):29-33.
2006: Thierry Passeron; Jean-Paul Ortonne
Use of the 308-nm excimer laser for psoriasis and vitiligo.
Clinics in dermatology 2006;24(1):33-42.
2005: Kristian Reich; Frank O Nestle; Kim A Papp; Jean-Paul Ortonne; Robert Evans; Cynthia Guzzo; Shu Li; Lisa T Dooley; Christopher E M Griffiths
Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial.
Lancet 2005;366(9494):1367-74.
2005: Jean-Paul Ortonne; A Khemis; J Y M Koo; J Choi
An open-label study of alefacept plus ultraviolet B light as combination therapy for chronic plaque psoriasis.
Journal of the European Academy of Dermatology and Venereology : JEADV 2005;19(5):556-63.
2005: Lionel Larribere; Caroline Hilmi; Mehdi Khaled; Cedric Gaggioli; Karine Bille; Patrick Auberger; Jean-Paul Ortonne; Robert Ballotti; Corine Bertolotto
The cleavage of microphthalmia-associated transcription factor, MITF, by caspases plays an essential role in melanocyte and melanoma cell apoptosis.
Genes & development 2005;19(17):1980-5.
2005: Valerie P I Vidal; Marie-Christine Chaboissier; Susanne Lützkendorf; George Cotsarelis; Pleasantine Mill; Chi-Chung Hui; Nicolas Ortonne; Jean-Paul Ortonne; Andreas Schedl
Sox9 is essential for outer root sheath differentiation and the formation of the hair stem cell compartment.
Current biology : CB 2005;15(15):1340-51.
2005: Sakari Reitamo; Jean-Paul Ortonne; C Sand; Frédéric Cambazard; Thomas Bieber; Regina Fölster-Holst; G Vena; J D Bos; P Fabbri; C Groenhoej Larsen
A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis.
The British journal of dermatology 2005;152(6):1282-9.
2005: A B Gottlieb; Christopher E M Griffiths; Vincent C Ho; Morad Lahfa; U Mrowietz; Dédée F Murrell; Jean-Paul Ortonne; G Todd; Robert Cherill; I Marks; S Emady-Azar; Carle Paul
Oral pimecrolimus in the treatment of moderate to severe chronic plaque-type psoriasis: a double-blind, multicentre, randomized, dose-finding trial.
The British journal of dermatology 2005;152(6):1219-27.
2005: Jean-Paul Ortonne; Thierry Passeron
Melanin pigmentary disorders: treatment update.
Dermatologic clinics 2005;23(2):209-26.
2005: Luc Duteil; Catherine Queille-Roussel; Jean-Paul Ortonne
[Assessment of the photosensitization potential of zinc gluconate].
Annales de dermatologie et de vénéréologie 2005;132(3):219-24.
2005: Annabelle Capt; Flavia Spirito; Eric Guaguere; Anne Spadafora; Jean-Paul Ortonne; Guerrino Meneguzzi
Inherited junctional epidermolysis bullosa in the German Pointer: establishment of a large animal model.
The Journal of investigative dermatology 2005;124(3):530-5.
2005: Thierry Passeron; Jean-Paul Ortonne
[The 308 nm excimer laser in dermatology].
Presse médicale (Paris, France : 1983) 2005;34(4):301-9.
2005: Cedric Gaggioli; Marcel Deckert; Guillaume ROBERT; Patricia Abbe; Michèle Batoz; Markus U Ehrengruber; Jean-Paul Ortonne; Robert Ballotti; Sophie Tartare-Deckert
HGF induces fibronectin matrix synthesis in melanoma cells through MAP kinase-dependent signaling pathway and induction of Egr-1.
Oncogene 2005;24(8):1423-33.
2005: Zeineb Alhaidari; Thierry Olivry; Anne Spadafora; Randall C Thomas; Christophe Perrin; Guerrino Meneguzzi; Jean-Paul Ortonne
Junctional epidermolysis bullosa in two domestic shorthair kittens.
Veterinary dermatology 2005;16(1):69-73.
2005: Kim A Papp; Kristine Breuer; Michael Meurer; Jean-Paul Ortonne; Paul C Potter; Yves de Prost; Miles J Davidson; Nathalie Barbier; Hans-Peter Goertz; Carle Paul
Long-term treatment of atopic dermatitis with pimecrolimus cream 1% in infants does not interfere with the development of protective antibodies after vaccination.
Journal of the American Academy of Dermatology 2005;52(2):247-53.
2005: Kim A Papp; Thomas Werfel; Regina Fölster-Holst; Jean-Paul Ortonne; Paul C Potter; Yves de Prost; Miles J Davidson; Nathalie Barbier; Hans-Peter Goertz; Carle Paul
Long-term control of atopic dermatitis with pimecrolimus cream 1% in infants and young children: a two-year study.
Journal of the American Academy of Dermatology 2005;52(2):240-6.
2005: Jean-Paul Ortonne; Neil Shear; Stephen Shumack; Eric Henninger
Impact of efalizumab on patient-reported outcomes in high-need psoriasis patients: results of the international, randomized, placebo-controlled Phase III Clinical Experience Acquired with Raptiva (CLEAR) trial [NCT00256139].
BMC dermatology 2005;5():13.
2005: Thierry Passeron; Jean-Paul Ortonne
Physiopathology and genetics of vitiligo.
Journal of autoimmunity 2005;25 Suppl():63-8.
2005: Pascale Peeters; Jean-Paul Ortonne; René Sitbon; Eric Guignard
Cost-effectiveness of once-daily treatment with calcipotriol/betamethasone dipropionate followed by calcipotriol alone compared with tacalcitol in the treatment of Psoriasis vulgaris.
Dermatology (Basel, Switzerland) 2005;211(2):139-45.
2005: Thierry Passeron; Frédéric Mantoux; Jean-Paul Ortonne
Genetic disorders of pigmentation.
Clinics in dermatology 2005;23(1):56-67.
2004: Thomas Ruzicka; Frederik Grønhøj Larsen; Dorota Galewicz; Attila Horváth; Peter-Jan Coenraads; Kristian Thestrup-Pedersen; Jean-Paul Ortonne; Christos Zouboulis; Martin Harsch; Thomas C Brown; Maurice Zultak
Oral alitretinoin (9-cis-retinoic acid) therapy for chronic hand dermatitis in patients refractory to standard therapy: results of a randomized, double-blind, placebo-controlled, multicenter trial.
Archives of dermatology 2004;140(12):1453-9.
2004: Kim A Papp; Doris Staab; John Harper; Paul Potter; Lluis Puig; Jean-Paul Ortonne; Stephen Molloy; Nathalie Barbier; Carle Paul
Effect of pimecrolimus cream 1% on the long-term course of pediatric atopic dermatitis.
International journal of dermatology 2004;43(12):978-83.
2004: Wassim Zakaria; Thierry Passeron; Nima Ostovari; Jean-Philippe Lacour; Jean-Paul Ortonne
308-nm excimer laser therapy in alopecia areata.
Journal of the American Academy of Dermatology 2004;51(5):837-8.
2004: Jean-Paul Ortonne; Francisco Camacho; Nicholas Wainwright; Louise Bergfelt; Wiete Westerhof; Diane Roseeuw
Safety and efficacy of combined use of 4-hydroxyanisole (mequinol) 2%/tretinoin 0.01% solution and sunscreen in solar lentigines.
Cutis; cutaneous medicine for the practitioner 2004;74(4):261-4.
2004: Thierry Passeron; Wassim Zakaria; Nima Ostovari; Christophe Perrin; Jean-Claude Larrouy; Jean-Philippe Lacour; Jean-Paul Ortonne
Efficacy of the 308-nm excimer laser in the treatment of mycosis fungoides.
Archives of dermatology 2004;140(10):1291-3.
2004: Rolf-Markus Szeimies; M J P Gerritsen; Girish Gupta; Jean-Paul Ortonne; Stefano Serresi; Jens Bichel; James H Lee; Terry L Fox; Agustín Alomar
Imiquimod 5% cream for the treatment of actinic keratosis: results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histology.
Journal of the American Academy of Dermatology 2004;51(4):547-55.
2004: Lionel Larribere; Mehdi Khaled; Sophie Tartare-Deckert; Roser Busca; Frederic Luciano; Karine Bille; Gäelle Valony; A Eychene; Patrick Auberger; Jean-Paul Ortonne; Robert Ballotti; Corine Bertolotto
PI3K mediates protection against TRAIL-induced apoptosis in primary human melanocytes.
Cell death and differentiation 2004;11(10):1084-91.
2004: Andrew Y Finlay; Jean-Paul Ortonne
Patient satisfaction with psoriasis therapies: an update and introduction to biologic therapy.
Journal of cutaneous medicine and surgery 2004;8(5):310-20.
2004: Thierry Passeron; Nima Ostovari; Wassim Zakaria; Eric Fontas; Jean-Claude Larrouy; Jean-Philippe Lacour; Jean-Paul Ortonne
Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo.
Archives of dermatology 2004;140(9):1065-9.
2004: Thierry Passeron; Philippe Bahadoran; Corine Bertolotto; Christine Chiaverini; Roser Buscà; Gäelle Valony; Karine Bille; Jean-Paul Ortonne; Robert Ballotti
Cyclic AMP promotes a peripheral distribution of melanosomes and stimulates melanophilin/Slac2-a and actin association.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2004;18(9):989-91.
2004: V Ferraro; Frédéric Mantoux; K Denis; M-A Lay-Macagno; Jean-Paul Ortonne; Jean-Philippe Lacour
[Hallucinations during treatment with hydrochloroquine].
Annales de dermatologie et de vénéréologie 2004;131(5):471-3.
2004: Jean-Paul Ortonne
[Daivobet: new therapeutic management for psoriasis. Introduction].
Annales de dermatologie et de vénéréologie 2004;131(5 Suppl):S3.
2004: K Angeli; Jean-Philippe Lacour; Frédéric Mantoux; J-C Roujeau; P André; C Truffot-Pernot; Jean-Paul Ortonne
[Mycobacterium fortuitum skin infection occurring after a facelift].
Annales de dermatologie et de vénéréologie 2004;131(2):198-200.
2004: Thierry Passeron; Jean-Philippe Lacour; Frédéric Mantoux; P Fabiani; D Dubois; Jean-Paul Ortonne
Chronic anal ulceration due to nicorandil.
The British journal of dermatology 2004;150(2):394-6.
2004: Jean-Paul Ortonne; R Kaufmann; M Lecha; M Goodfield
Efficacy of treatment with calcipotriol/betamethasone dipropionate followed by calcipotriol alone compared with tacalcitol for the treatment of psoriasis vulgaris: a randomised, double-blind trial.
Dermatology (Basel, Switzerland) 2004;209(4):308-13.
2004: Nima Ostovari; Thierry Passeron; Wassim Zakaria; Eric Fontas; J C Larouy; J F Blot; Jean-Philippe Lacour; Jean-Paul Ortonne
Treatment of vitiligo by 308-nm excimer laser: an evaluation of variables affecting treatment response.
Lasers in surgery and medicine 2004;35(2):152-6.
2004: Thierry Passeron; Wassim Zakaria; Nima Ostovari; Frédéric Mantoux; Jean-Philippe Lacour; Jean-Paul Ortonne
Treatment of erosive oral lichen planus by the 308 nm excimer laser.
Lasers in surgery and medicine 2004;34(3):205.
2004: Jean-Paul Ortonne; Jörg C Prinz
Alefacept: a novel and selective biologic agent for the treatment of chronic plaque psoriasis.
European journal of dermatology : EJD 2004;14(1):41-5.
2004: Jean-Paul Ortonne
Redefining clinical response in psoriasis: targeting the pathological basis of disease.
Journal of drugs in dermatology : JDD 2004;3(1):13-20.
2004: Thierry Passeron; Frédéric Mantoux; Jean-Philippe Lacour; Pierre-Marie Roger; Thierry Fosse; A Iannelli; Jean-Paul Ortonne
Infectious and toxic cellulitis due to suicide attempt by subcutaneous injection of ricin.
The British journal of dermatology 2004;150(1):154.
2003: Annabelle Capt; Flavia Spirito; Richard Guyon; Catherine André; Jean-Paul Ortonne; Guerrino Meneguzzi
Cloning of laminin gamma2 cDNA and chromosome mapping of the genes for the dog adhesion ligand laminin 5.
Biochemical and biophysical research communications 2003;312(4):1256-65.
2003: Alexandra Charlesworth; Laurent Gagnoux-Palacios; Maryse Bonduelle; Jean-Paul Ortonne; Linda De Raeve; Guerrino Meneguzzi
Identification of a lethal form of epidermolysis bullosa simplex associated with a homozygous genetic mutation in plectin.
The Journal of investigative dermatology 2003;121(6):1344-8.
2003: Maryline Allegra; Laurent Gagnoux-Palacios; Yannick Gache; Stéphanie Roques; Gilles G Lestringant; Jean-Paul Ortonne; Guerrino Meneguzzi
Rapid decay of alpha6 integrin caused by a mis-sense mutation in the propeller domain results in severe junctional epidermolysis bullosa with pyloric atresia.
The Journal of investigative dermatology 2003;121(6):1336-43.
2003: Laurent Turchi; Anne-Amandine Chassot; Isabelle Bourget; Christine Baldescchi; Jean-Paul Ortonne; Guerrino Meneguzzi; emmanuel lemichez; Gilles Ponzio
Cross-talk between RhoGTPases and stress activated kinases for matrix metalloproteinase-9 induction in response to keratinocytes injury.
The Journal of investigative dermatology 2003;121(6):1291-300.
2003: Mehdi Khaled; Lionel Larribere; Karine Bille; Jean-Paul Ortonne; Robert Ballotti; Corine Bertolotto
Microphthalmia associated transcription factor is a target of the phosphatidylinositol-3-kinase pathway.
The Journal of investigative dermatology 2003;121(4):831-6.
2003: Thierry Passeron; Jean-Paul Ortonne
[Skin ageing and its prevention].
Presse médicale (Paris, France : 1983) 2003;32(31):1474-82.
2003: Christine Baldeschi; Yannick Gache; Anke Rattenholl; Pascale Bouillé; Olivier Danos; Jean-Paul Ortonne; Leena Bruckner-Tuderman; Guerrino Meneguzzi
Genetic correction of canine dystrophic epidermolysis bullosa mediated by retroviral vectors.
Human molecular genetics 2003;12(15):1897-905.
2003: Cedric Gaggioli; Roser Buscà; Patricia Abbe; Jean-Paul Ortonne; Robert Ballotti
Microphthalmia-associated transcription factor (MITF) is required but is not sufficient to induce the expression of melanogenic genes.
Pigment cell research / sponsored by the European Society for Pigment Cell Research and the International Pigment Cell Society 2003;16(4):374-82.
2003: Frédéric Mantoux; K Sebban; E Cassuto; Jean-Philippe Lacour; Jean-Paul Ortonne
[Staphylococcal nodular lymphangitis in a renal transplant recipient].
Presse médicale (Paris, France : 1983) 2003;32(24):1123-4.
2003: Jean-Paul Ortonne
Anti-inflammatory vs. inflammatory treatments for actinic keratoses.
Journal of cosmetic dermatology 2003;2(3-4):135-40.
2003: Jean-Paul Ortonne
Clinical response to alefacept: results of a phase 3 study of intramuscular administration of alefacept in patients with chronic plaque psoriasis.
Journal of the European Academy of Dermatology and Venereology : JEADV 2003;17 Suppl 2():12-6.
2003: Christelle Coraux; Caroline Hilmi; Matthieu Rouleau; Anne Spadafora; Jocelyne Hinnrasky; Jean-Paul Ortonne; Christian Dani; Daniel Aberdam
Reconstituted skin from murine embryonic stem cells.
Current biology : CB 2003;13(10):849-53.
2003: Thierry Passeron; Valérie Olivier; Luc Duteil; François Desruelles; Eric Fontas; Jean-Paul Ortonne
The new 940-nanometer diode laser: an effective treatment for leg venulectasia.
Journal of the American Academy of Dermatology 2003;48(5):768-74.
2003: Jean-Paul Ortonne; Thomas Schwarz
[Clinical aspects and pathogenesis of UV-induced pigmentary disorders].
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2003;1(4):274-84.
2003: Philippe Bahadoran; Roser Busca; Christine Chiaverini; Wendy Westbroek; Julien Lambert; Karine Bille; Gäelle Valony; Mitsunori Fukuda; Jean-Marie Naeyaert; Jean-Paul Ortonne; Robert Ballotti
Characterization of the molecular defects in Rab27a, caused by RAB27A missense mutations found in patients with Griscelli syndrome.
The Journal of biological chemistry 2003;278(13):11386-92.
2003: Jean-Paul Ortonne; Mark Lebwohl; Christopher Em Griffiths
Alefacept-induced decreases in circulating blood lymphocyte counts correlate with clinical response in patients with chronic plaque psoriasis.
European journal of dermatology : EJD 2003;13(2):117-23.
2003: Christine Chiavérini; Bernadette Baldin; Rose-Marie Chichmanian; Jean-Paul Ortonne; Jean-Philippe Lacour
[Bupropion (Zyban) induced urticaria: 2 cases].
Annales de dermatologie et de vénéréologie 2003;130(2 Pt 1):208-9.
2003: Philippe Bahadoran; Jean-Paul Ortonne; Robert Ballotti; Geneviève de Saint Basile
Comment on Elejalde syndrome and relationship with Griscelli syndrome.
American journal of medical genetics. Part A 2003;116A(4):408-9.
2003: Philippe Bahadoran; Robert Ballotti; Jean-Paul Ortonne
Hypomelanosis, immunity, central nervous system: no more "and", not the end.
American journal of medical genetics. Part A 2003;116A(4):334-7.
2003: Christine Chiavérini; Gilles Halimi; Denis Ouzan; Philippe Halfon; Jean-Paul Ortonne; Jean-Philippe Lacour
Porphyria cutanea tarda, C282Y, H63D and S65C HFE gene mutations and hepatitis C infection: a study from southern France.
Dermatology (Basel, Switzerland) 2003;206(3):212-6.
2002: Valérie Olivier; Jean-Philippe Lacour; Aline Mousnier; Rodolphe Garraffo; Roger A Monteil; Jean-Paul Ortonne
Treatment of chronic erosive oral lichen planus with low concentrations of topical tacrolimus: an open prospective study.
Archives of dermatology 2002;138(10):1335-8.
2002: Mehdi Khaled; Lionel Larribere; Karine Bille; Edith Aberdam; Jean-Paul Ortonne; Robert Ballotti; Corine Bertolotto
Glycogen synthase kinase 3beta is activated by cAMP and plays an active role in the regulation of melanogenesis.
The Journal of biological chemistry 2002;277(37):33690-7.
2002: Flavia Spirito; Alexandra Charlesworth; Keith Linder; Jean-Paul Ortonne; John Baird; Guerrino Meneguzzi
Animal models for skin blistering conditions: absence of laminin 5 causes hereditary junctional mechanobullous disease in the Belgian horse.
The Journal of investigative dermatology 2002;119(3):684-91.
2002: Alexander Kapp; Kim A Papp; Ann Bingham; Regina Fölster-Holst; Jean-Paul Ortonne; Paul C Potter; Wayne Gulliver; Carle Paul; Stephen Molloy; Nathalie Barbier; Mark Thurston; Yves de Prost
Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory drug.
The Journal of allergy and clinical immunology 2002;110(2):277-84.
2002: Laurent Turchi; Anne-Amandine Chassot; Roger Rezzonico; Karen Yeow; Agnès Loubat; Bernard Ferrua; Gaëlle Lenegrate; Jean-Paul Ortonne; Gilles Ponzio
Dynamic characterization of the molecular events during in vitro epidermal wound healing.
The Journal of investigative dermatology 2002;119(1):56-63.
2002: Christophe Perrin; Robert Baran; Anne Pisani; Jean-Paul Ortonne; Jean-François Michiels
The onychomatricoma: additional histologic criteria and immunohistochemical study.
The American Journal of dermatopathology 2002;24(3):199-203.
2002: Luc Duteil; Catherine Queille-Roussel; B Lorenz; R Thieroff-Ekerdt; Jean-Paul Ortonne
A randomized, controlled study of the safety and efficacy of topical corticosteroid treatments of sunburn in healthy volunteers.
Clinical and experimental dermatology 2002;27(4):314-8.
2002: Christine Chiavérini; J Y Kurzenne; A Rogopoulos; Jean-Paul Ortonne; Jean-Philippe Lacour
[Noninvoluting congenital hemangioma: 2 cases].
Annales de dermatologie et de vénéréologie 2002;129(5 Pt 1):735-7.
2002: Lyn Guenther; Jean-Paul Ortonne
Pathophysiology of psoriasis: science behind therapy.
Journal of cutaneous medicine and surgery 2002;6(3 Suppl):2-7.
2002: Thierry Virolle; Christelle Coraux; Olivier Ferrigno; Laurence Cailleteau; Jean-Paul Ortonne; Philippe Pognonec; Daniel Aberdam
Binding of USF to a non-canonical E-box following stress results in a cell-specific derepression of the lama3 gene.
Nucleic acids research 2002;30(8):1789-98.
2002: Jean-Paul Ortonne
From actinic keratosis to squamous cell carcinoma.
The British journal of dermatology 2002;146 Suppl 61():20-3.
2002: Jean-Paul Ortonne
Photobiology and genetics of malignant melanoma.
The British journal of dermatology 2002;146 Suppl 61():11-6.
2002: Jean-Paul Ortonne
Photoprotective properties of skin melanin.
The British journal of dermatology 2002;146 Suppl 61():7-10.
2002: Christine Chiavérini; Thierry Passeron; Jean-Paul Ortonne
Treatment of vitiligo by topical calcipotriol.
Journal of the European Academy of Dermatology and Venereology : JEADV 2002;16(2):137-8.
2002: WS Douglas; Yves Poulin; Jacques Decroix; Jean-Paul Ortonne; U Mrowietz; Wayne Gulliver; A L Krogstad; F G Larsen; L Iglesias; C Buckley; Adrian Bibby
A new calcipotriol/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris.
Acta dermato-venereologica 2002;82(2):131-5.
2002: Frédéric Mantoux; J Castanet; Christophe Perrin; J G Fuzibet; Jean-Philippe Lacour; Jean-Paul Ortonne
[Cutaneous Waldenström's macroglobulinemia].
Annales de dermatologie et de vénéréologie 2002;129(1 Pt 1):53-5.
2001: Yannick Gache; Maryline Allegra; C Bodemer; A Pisani-Spadafora; Y de Prost; Jean-Paul Ortonne; Guerrino Meneguzzi
Genetic bases of severe junctional epidermolysis bullosa presenting spontaneous amelioration with aging.
Human molecular genetics 2001;10(21):2453-61.
2001: Flavia Spirito; Stéphane Chavanas; Catherine Prost-Squarcioni; L Pulkkinen; Sylvie Fraitag; Christine Bodemer; Jean-Paul Ortonne; Guerrino Meneguzzi
Reduced expression of the epithelial adhesion ligand laminin 5 in the skin causes intradermal tissue separation.
The Journal of biological chemistry 2001;276(22):18828-35.
2001: Laurent Gagnoux-Palacios; Maryline Allegra; Flavia Spirito; O Pommeret; C Romero; Jean-Paul Ortonne; Guerrino Meneguzzi
The short arm of the laminin gamma2 chain plays a pivotal role in the incorporation of laminin 5 into the extracellular matrix and in cell adhesion.
The Journal of cell biology 2001;153(4):835-50.
2001: O Dereure; J Vailly; B Lagrange; Guerrino Meneguzzi; Jean-Paul Ortonne; B Guillot
Dominant dystrophic epidermolysis bullosa associated with pyloric stenosis and congenital absence of skin.
Archives of dermatology 2001;137(5):665-6.
2001: Olivier Ferrigno; Thierry Virolle; Z Djabari; Jean-Paul Ortonne; R J White; Daniel Aberdam
Transposable B2 SINE elements can provide mobile RNA polymerase II promoters.
Nature genetics 2001;28(1):77-81.
2001: Catherine Queille-Roussel; Carle Paul; Luc Duteil; M C Lefebvre; G Rapatz; M Zagula; Jean-Paul Ortonne
The new topical ascomycin derivative SDZ ASM 981 does not induce skin atrophy when applied to normal skin for 4 weeks: a randomized, double-blind controlled study.
The British journal of dermatology 2001;144(3):507-13.
2001: Philippe Bahadoran; Edith Aberdam; Frédéric Mantoux; Roser Buscà; Karine Bille; Nevin Yalman; Geneviève de Saint Basile; R Casaroli-Marano; Jean-Paul Ortonne; Robert Ballotti
Rab27a: A key to melanosome transport in human melanocytes.
The Journal of cell biology 2001;152(4):843-50.
2000: O Roux; François Desruelles; Pascal Delaunay; Yves Le Fichoux; Jean-Paul Ortonne
Ticks and photo safari in South Africa.
The British journal of dermatology 2000;143(5):1109-10.
2000: C Verastegui; Karine Bille; Jean-Paul Ortonne; Robert Ballotti
Regulation of the microphthalmia-associated transcription factor gene by the Waardenburg syndrome type 4 gene, SOX10.
The Journal of biological chemistry 2000;275(40):30757-60.
2000: Thierry Virolle; Z Djabari; Jean-Paul Ortonne; Daniel Aberdam
DNA conformation driven by AP-1 triggers cell-specific expression via a strong epithelial enhancer.
EMBO reports 2000;1(4):328-33.
2000: Jean-Paul Ortonne
[Psoriasis: assessment of quality of life].
Annales de dermatologie et de vénéréologie 2000;127 Suppl 2():2S19-22.
2000: Edith Aberdam; Patrick Auberger; Jean-Paul Ortonne; Robert Ballotti
Neprilysin, a novel target for ultraviolet B regulation of melanogenesis via melanocortins.
The Journal of investigative dermatology 2000;115(3):381-7.
2000: François Desruelles; J P Lacour; P Chevallier; A Courdi; Thierry Passeron; Jean-Paul Ortonne
Radiation myo-fasciitis.
Acta dermato-venereologica 2000;80(4):310-1.
2000: Roser Buscà; Patricia Abbe; Frédéric Mantoux; Edith Aberdam; Carole Peyssonnaux; Alain Eychène; Jean-Paul Ortonne; Robert Ballotti
Ras mediates the cAMP-dependent activation of extracellular signal-regulated kinases (ERKs) in melanocytes.
The EMBO journal 2000;19(12):2900-10.
2000: Catherine Queille-Roussel; Michael Graeber; Mark Thurston; JM Lachapelle; J Decroix; C de Cuyper; Jean-Paul Ortonne
SDZ ASM 981 is the first non-steroid that suppresses established nickel contact dermatitis elicited by allergen challenge.
Contact dermatitis 2000;42(6):349-50.
2000: Thierry Passeron; Philippe Bahadoran; pascal pugliese; Jean-Philippe Lacour; Jean-Paul Ortonne
Lack of hypocomplementemia in chronic urticaria.
Archives of dermatology 2000;136(4):558-9.
2000: O Roux; François Desruelles; Jean-Philippe Lacour; Jean-Paul Ortonne
[Pyoderma gangrenosum simulating erysipelas].
Presse médicale (Paris, France : 1983) 2000;29(8):421.
2000: Valérie Olivier; Jean-Philippe Lacour; J Castanet; Christophe Perrin; Jean-Paul Ortonne
[Cheilitis granulomatosa in a child].
Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie 2000;7(3):274-7.
2000: C Verastegui; Corine Bertolotto; Karine Bille; Patricia Abbe; Jean-Paul Ortonne; Robert Ballotti
TFE3, a transcription factor homologous to microphthalmia, is a potential transcriptional activator of tyrosinase and TyrpI genes.
Molecular endocrinology (Baltimore, Md.) 2000;14(3):449-56.
2000: Valérie Olivier; François Desruelles; Eric Cua; Evelyne Bernard; Pierre-Marie Roger; Pascal Del Giudice; Jean-Philippe Lacour; Pierre Dellamonica; Jean-Paul Ortonne
[Recurrent infectious and metastatic cellulitis cause by Escherichia coli].
Presse médicale (Paris, France : 1983) 2000;29(1):19-20.
1999: François Desruelles; Pascal Delaunay; Pierre Marty; Pascal Del Giudice; Frédéric Mantoux; Yves Le Fichoux; Jean-Paul Ortonne
[Myiasis caused by Dermatoba hominis after an organized tours in Amazonia].
Presse médicale (Paris, France : 1983) 1999;28(40):2223-5.
1999: François Desruelles; Martine Gari-Toussaint; Jean-Philippe Lacour; Pierre Marty; Yves Le Fichoux; Jean-Paul Ortonne
Tinea versicolor mimicking pityriasis rotunda.
International journal of dermatology 1999;38(12):948-9.
1999: Stéphane Chavanas; Yannick Gache; J Vailly; J Kanitakis; L Pulkkinen; Jouni Uitto; Jean-Paul Ortonne; Guerrino Meneguzzi
Splicing modulation of integrin beta4 pre-mRNA carrying a branch point mutation underlies epidermolysis bullosa with pyloric atresia undergoing spontaneous amelioration with ageing.
Human molecular genetics 1999;8(11):2097-105.
1999: C Chiaverini; François Desruelles; Jean-Philippe Lacour; Jean-Paul Ortonne
[Psoriasis. Treatment].
Presse médicale (Paris, France : 1983) 1999;28(23):1266-73.
1999: Thierry Passeron; Philippe Bahadoran; Jean-Philippe Lacour; Jean-Paul Ortonne
[Psoriasis. Clinical cutaneous aspects].
Presse médicale (Paris, France : 1983) 1999;28(23):1246-50.
1999: Jean-Philippe Lacour; J Castanet; Patrick Boutté; Jean-Paul Ortonne
[Antiseptic treatment of the umbilical cord in newborns: survey and recommendations].
Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie 1999;6(6):631-4.
1999: Thierry Passeron; François Desruelles; Thierry Fosse; M Weiller; Christophe Perrin; Jean-Philippe Lacour; Jean-Paul Ortonne
Disseminated papulopustular eruption due to Mycobacterium fortuitum in an immunocompetent patient.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1999;28(4):924-5.
1999: Thierry Passeron; Philippe Bahadoran; Jean-Philippe Lacour; Christophe Perrin; D Gilbert; S Benzaken; J G Fuzibet; Jean-Paul Ortonne
Paraneoplastic pemphigus presenting as erosive lichen planus.
The British journal of dermatology 1999;140(3):552-3.
1999: Walter Englaro; Philippe Bahadoran; Corine Bertolotto; Roser Buscà; Benoît Dérijard; Antonia Livolsi; Jean-François Peyron; Jean-Paul Ortonne; Robert Ballotti
Tumor necrosis factor alpha-mediated inhibition of melanogenesis is dependent on nuclear factor kappa B activation.
Oncogene 1999;18(8):1553-9.
1999: Frédéric Mantoux; Philippe Bahadoran; Christophe Perrin; C Bermon; Jean-Philippe Lacour; Jean-Paul Ortonne
[Flutamide-induced late cutaneous pseudoporphyria].
Annales de dermatologie et de vénéréologie 1999;126(2):150-2.
1998: Yannick Gache; C Romero-Graillet; Anne Spadafora; Catherine Lépinard; Philippe Descamps; C B Bardon; Jean-Paul Ortonne; Guerrino Meneguzzi
A novel homozygous mutation affecting integrin alpha6 in a case of junctional epidermolysis bullosa with pyloric atresia detected in utero by ultrasound examination.
The Journal of investigative dermatology 1998;111(5):914-6.
1998: J Vailly; Laurent Gagnoux-Palacios; E Dell'Ambra; C Roméro; M Pinola; Giovanna Zambruno; Michele De Luca; Jean-Paul Ortonne; Guerrino Meneguzzi
Corrective gene transfer of keratinocytes from patients with junctional epidermolysis bullosa restores assembly of hemidesmosomes in reconstructed epithelia.
Gene therapy 1998;5(10):1322-32.
1998: François Desruelles; J Castanet; V Botcazou; Jean-Philippe Lacour; Jean-Paul Ortonne
[Koebner phenomenon and multiple morphea].
Annales de dermatologie et de vénéréologie 1998;125(9):604.
1998: Corine Bertolotto; Patricia Abbe; TJ Hemesath; Karine Bille; David E Fisher; Jean-Paul Ortonne; Robert Ballotti
Microphthalmia gene product as a signal transducer in cAMP-induced differentiation of melanocytes.
The Journal of cell biology 1998;142(3):827-35.
1998: Edith Aberdam; Corine Bertolotto; Elena V Sviderskaya; V de Thillot; TJ Hemesath; David E Fisher; Dorothy C Bennett; Jean-Paul Ortonne; Robert Ballotti
Involvement of microphthalmia in the inhibition of melanocyte lineage differentiation and of melanogenesis by agouti signal protein.
The Journal of biological chemistry 1998;273(31):19560-5.
1998: Thierry Virolle; M N Monthouel; Z Djabari; Jean-Paul Ortonne; Guerrino Meneguzzi; Daniel Aberdam
Three activator protein-1-binding sites bound by the Fra-2.JunD complex cooperate for the regulation of murine laminin alpha3A (lama3A) promoter activity by transforming growth factor-beta.
The Journal of biological chemistry 1998;273(28):17318-25.
1998: François Desruelles; Pierre Marty; Christophe Perrin; J D De Saint Florent; Jean-Philippe Lacour; Yves Le Fichoux; Jean-Paul Ortonne
[Endemic subcutaneous Dirofilaria repens filariasis in Southern France].
Annales de dermatologie et de vénéréologie 1998;125(6-7):423-4.
1998: François Desruelles; Jean-Philippe Lacour; Frédéric Mantoux; Jean-Paul Ortonne
Divided nevus of the penis: an unusual location.
Archives of dermatology 1998;134(7):879-80.
1998: Roser Buscà; Corine Bertolotto; Patricia Abbe; Walter Englaro; T Ishizaki; S Narumiya; P Boquet; Jean-Paul Ortonne; Robert Ballotti
Inhibition of Rho is required for cAMP-induced melanoma cell differentiation.
Molecular biology of the cell 1998;9(6):1367-78.
1998: Walter Englaro; Corine Bertolotto; Roser Buscà; A Brunet; G Pagès; Jean-Paul Ortonne; Robert Ballotti
Inhibition of the mitogen-activated protein kinase pathway triggers B16 melanoma cell differentiation.
The Journal of biological chemistry 1998;273(16):9966-70.
1998: Corine Bertolotto; Karine Bille; Jean-Paul Ortonne; Robert Ballotti
In B16 melanoma cells, the inhibition of melanogenesis by TPA results from PKC activation and diminution of microphthalmia binding to the M-box of the tyrosinase promoter.
Oncogene 1998;16(13):1665-70.
1998: François Desruelles; Philippe Bahadoran; Jean-Philippe Lacour; Christophe Perrin; J Santini; Jean-Paul Ortonne
Giant oral aphthous ulcers induced by nicorandil.
The British journal of dermatology 1998;138(4):712-3.
1998: Walter Englaro; Benoît Dérijard; Jean-Paul Ortonne; Robert Ballotti
Solar ultraviolet light activates extracellular signal-regulated kinases and the ternary complex factor in human normal keratinocytes.
Oncogene 1998;16(5):661-4.
1998: Corine Bertolotto; Roser Buscà; Patricia Abbe; Karine Bille; Edith Aberdam; Jean-Paul Ortonne; Robert Ballotti
Different cis-acting elements are involved in the regulation of TRP1 and TRP2 promoter activities by cyclic AMP: pivotal role of M boxes (GTCATGTGCT) and of microphthalmia.
Molecular and cellular biology 1998;18(2):694-702.
1997: Philippe Bahadoran; Jean-Philippe Lacour; A Terrisse; Jean-Paul Ortonne
Congenital constriction band of the trunk.
Pediatric dermatology 1997;14(6):470-2.
1997: Laurent Gagnoux-Palacios; Yannick Gache; Jean-Paul Ortonne; Guerrino Meneguzzi
Hemidesmosome assembly assessed by expression of a wild-type integrin beta 4 cDNA in junctional epidermolysis bullosa keratinocytes.
Laboratory investigation; a journal of technical methods and pathology 1997;77(5):459-68.
1997: Christophe Perrin; Jean-François Michiels; A Pisani; Jean-Paul Ortonne
Anatomic distribution of melanocytes in normal nail unit: an immunohistochemical investigation.
The American Journal of dermatopathology 1997;19(5):462-7.
1997: Olivier Ferrigno; Thierry Virolle; M F Galliano; N Chauvin; Jean-Paul Ortonne; Guerrino Meneguzzi; Daniel Aberdam
Murine laminin alpha3A and alpha3B isoform chains are generated by usage of two promoters and alternative splicing.
The Journal of biological chemistry 1997;272(33):20502-7.
1997: Stéphane Chavanas; Yannick Gache; Gianluca Tadini; L Pulkkinen; Jouni Uitto; Jean-Paul Ortonne; Guerrino Meneguzzi
A homozygous in-frame deletion in the collagenous domain of bullous pemphigoid antigen BP180 (type XVII collagen) causes generalized atrophic benign epidermolysis bullosa.
The Journal of investigative dermatology 1997;109(1):74-8.
1997: J Castanet; Fabrice Monpoux; R Mariani; Jean-Paul Ortonne; Jean-Philippe Lacour
Demodicidosis in an immunodeficient child.
Pediatric dermatology 1997;14(3):219-20.
1997: Philippe Bahadoran; Jean-Philippe Lacour; Jean-Paul Ortonne
Leukaemia cutis at the site of prior herpes zoster.
The British journal of dermatology 1997;136(3):465.
1997: C Roméro-Graillet; Edith Aberdam; M Clément; Jean-Paul Ortonne; Robert Ballotti
Nitric oxide produced by ultraviolet-irradiated keratinocytes stimulates melanogenesis.
The Journal of clinical investigation 1997;99(4):635-42.
1997: J Castanet; Jean-Philippe Lacour; C Chartier; Christophe Perrin; T Martin; E Grosshans; Jean-Paul Ortonne
[Chronic edema, monoclonal dysglobulinemia and profuse telangiectasia: a distinct entity?].
Annales de dermatologie et de vénéréologie 1997;124(10):717-20.
1997: Philippe Bahadoran; Jean-Philippe Lacour; Jean-Paul Ortonne
[Amniotic band syndrome].
Annales de dermatologie et de vénéréologie 1997;124(5):416-20.
1997: Jean-Paul Ortonne
Oral isotretinoin treatment policy. Do we all agree?
Dermatology (Basel, Switzerland) 1997;195 Suppl 1():34-7; discussion 38-40.
1997: J Castanet; Jean-Philippe Lacour; B Taillan; Christophe Perrin; G Garnier; Jean-Paul Ortonne
Two cases of localized B-cell lymphoma in the acquired immunodeficiency syndrome.
Dermatology (Basel, Switzerland) 1997;194(2):185-7.
1997: J Castanet; Jean-Paul Ortonne
Hair melanin and hair color.
EXS 1997;78():209-25.
1996: Roser Buscà; Corine Bertolotto; Jean-Paul Ortonne; Robert Ballotti
Inhibition of the phosphatidylinositol 3-kinase/p70(S6)-kinase pathway induces B16 melanoma cell differentiation.
The Journal of biological chemistry 1996;271(50):31824-30.
1996: Stéphane Chavanas; L Pulkkinen; Yannick Gache; F J Smith; W H McLean; J Uitto; Jean-Paul Ortonne; Guerrino Meneguzzi
A homozygous nonsense mutation in the PLEC1 gene in patients with epidermolysis bullosa simplex with muscular dystrophy.
The Journal of clinical investigation 1996;98(10):2196-200.
1996: C Roméro-Graillet; Edith Aberdam; N Biagoli; W Massabni; Jean-Paul Ortonne; Robert Ballotti
Ultraviolet B radiation acts through the nitric oxide and cGMP signal transduction pathway to stimulate melanogenesis in human melanocytes.
The Journal of biological chemistry 1996;271(45):28052-6.
1996: Jean-Paul Ortonne
Aetiology and pathogenesis of psoriasis.
The British journal of dermatology 1996;135 Suppl 49():1-5.
1996: Laurent Gagnoux-Palacios; J Vailly; M Durand-Clement; Ernst Wagner; Jean-Paul Ortonne; Guerrino Meneguzzi
Functional Re-expression of laminin-5 in laminin-gamma2-deficient human keratinocytes modifies cell morphology, motility, and adhesion.
The Journal of biological chemistry 1996;271(31):18437-44.
1996: Corine Bertolotto; Karine Bille; Jean-Paul Ortonne; Robert Ballotti
Regulation of tyrosinase gene expression by cAMP in B16 melanoma cells involves two CATGTG motifs surrounding the TATA box: implication of the microphthalmia gene product.
The Journal of cell biology 1996;134(3):747-55.
1996: C Perrin; A Pisani; M Demarchez; J F Michiel; Jean-Paul Ortonne
Vla and alpha 6 beta 4 integrin expression in neuroendocrine carcinomas of the skin (their xenografts on nude mice and a corresponding primary culture).
Journal of cutaneous pathology 1996;23(3):223-8.
1996: Yannick Gache; Stéphane Chavanas; J P Lacour; Gerhard Wiche; Katsushi Owaribe; Guerrino Meneguzzi; Jean-Paul Ortonne
Defective expression of plectin/HD1 in epidermolysis bullosa simplex with muscular dystrophy.
The Journal of clinical investigation 1996;97(10):2289-98.
1996: C Miquel; Laurent Gagnoux-Palacios; M Durand-Clement; P Marinkovich; Jean-Paul Ortonne; Guerrino Meneguzzi
Establishment and characterization of cell line LSV5 that retains the altered adhesive properties of human junctional epidermolysis bullosa keratinocytes.
Experimental cell research 1996;224(2):279-90.
1996: S Rodot; Jean-Philippe Lacour; L Van Elslande; Jean-Paul Ortonne
[Idiopathic CD4 lymphocytopenia].
Annales de dermatologie et de vénéréologie 1996;123(12):852-6.
1996: Pascal Del Giudice; E Bernard; C Perrin; Pierre Marty; Yves Le Fichoux; Jean-Paul Ortonne; J F Michiels; Pierre Dellamonica
[Subcutaneous cysticercosis].
Annales de dermatologie et de vénéréologie 1996;123(8):474-7.
1996: J Castanet; S Rodot; Jean-Philippe Lacour; L Van Elslande; Christophe Perrin; J Durant; Jean-Paul Ortonne
Chronic varicella presenting as disseminated pinpoint-sized papules in a man infected with the human immunodeficiency virus.
Dermatology (Basel, Switzerland) 1996;192(1):84-6.
1996: S Rodot; Jean-Philippe Lacour; L Van Elslande; C Cognard; J Castanet; Jean-Paul Ortonne
[Extracutaneous manifestations of neutrophilic dermatosis].
Annales de dermatologie et de vénéréologie 1996;123(2):129-34.
1995: F Vidal; C Baudoin; C Miquel; M F Galliano; Angela M Christiano; J Uitto; Jean-Paul Ortonne; Guerrino Meneguzzi
Cloning of the laminin alpha 3 chain gene (LAMA3) and identification of a homozygous deletion in a patient with Herlitz junctional epidermolysis bullosa.
Genomics 1995;30(2):273-80.
1995: Walter Englaro; Roger Rezzonico; M Durand-Clément; D Lallemand; Jean-Paul Ortonne; Robert Ballotti
Mitogen-activated protein kinase pathway and AP-1 are activated during cAMP-induced melanogenesis in B-16 melanoma cells.
The Journal of biological chemistry 1995;270(41):24315-20.
1995: M F Galliano; Daniel Aberdam; A Aguzzi; Jean-Paul Ortonne; Guerrino Meneguzzi
Cloning and complete primary structure of the mouse laminin alpha 3 chain. Distinct expression pattern of the laminin alpha 3A and alpha 3B chain isoforms.
The Journal of biological chemistry 1995;270(37):21820-6.
1995: J Castanet; Jean-Philippe Lacour; Christophe Perrin; S Rodot; Jean-Paul Ortonne
Cutaneous vasculitis with lesions mimicking degos' disease and revealing Crohn's disease.
Acta dermato-venereologica 1995;75(5):408-9.
1995: F Vidal; Daniel Aberdam; C Miquel; Angela M Christiano; L Pulkkinen; J Uitto; Jean-Paul Ortonne; Guerrino Meneguzzi
Integrin beta 4 mutations associated with junctional epidermolysis bullosa with pyloric atresia.
Nature genetics 1995;10(2):229-34.
1995: Sirpa Kivirikko; J A McGrath; C Baudoin; Daniel Aberdam; S Ciatti; M G Dunnill; James R McMillan; Robin A J Eady; Jean-Paul Ortonne; Guerrino Meneguzzi
A homozygous nonsense mutation in the alpha 3 chain gene of laminin 5 (LAMA3) in lethal (Herlitz) junctional epidermolysis bullosa.
Human molecular genetics 1995;4(5):959-62.
1995: J Vailly; L Pulkkinen; C Miquel; Angela M Christiano; D Gerecke; Robert E Burgeson; J Uitto; Jean-Paul Ortonne; Guerrino Meneguzzi
Identification of a homozygous one-basepair deletion in exon 14 of the LAMB3 gene in a patient with Herlitz junctional epidermolysis bullosa and prenatal diagnosis in a family at risk for recurrence.
The Journal of investigative dermatology 1995;104(4):462-6.
1995: J Vailly; L Pulkkinen; Angela M Christiano; K Tryggvason; J Uitto; Jean-Paul Ortonne; Guerrino Meneguzzi
Identification of a homozygous exon-skipping mutation in the LAMC2 gene in a patient with Herlitz's junctional epidermolysis bullosa.
The Journal of investigative dermatology 1995;104(3):434-7.
1995: S Rodot; Jean-Philippe Lacour; L van Elslande; J Castanet; François Desruelles; Jean-Paul Ortonne
Ecthyma gangrenosum caused by Klebsiella pneumoniae.
International journal of dermatology 1995;34(3):216-7.
1995: S Rodot; Jean-Philippe Lacour; L Van Elslande; Christophe Perrin; J Castanet; Jean-Paul Ortonne
Cholesterol crystal embolization presenting as erythema induratum of bazin.
Acta dermato-venereologica 1995;75(2):160-1.
1995: Jean-Philippe Lacour; Jean-Paul Ortonne
[Genetics of vitiligo].
Annales de dermatologie et de vénéréologie 1995;122(4):167-71.
1995: J Castanet; Jean-Philippe Lacour; M Toussaint-Gary; Christophe Perrin; S Rodot; Jean-Paul Ortonne
[Alternaria tenuissima plurifocal cutaneous infection].
Annales de dermatologie et de vénéréologie 1995;122(3):115-8.
1995: C Perrin; S Rodot; Jean-Paul Ortonne; J F Michiels
[Targetoid hemosiderotic hemangioma].
Annales de dermatologie et de vénéréologie 1995;122(3):111-4.
1994: Jean-Philippe Lacour; P el Baze; J Castanet; D Dubois; M Poudenx; Jean-Paul Ortonne
Diving suit dermatitis caused by Pseudomonas aeruginosa: two cases.
Journal of the American Academy of Dermatology 1994;31(6):1055-6.
1994: J Castanet; Jean-Philippe Lacour; Christophe Perrin; P Brun; Jean-Paul Ortonne
Juvenile pityriasis rubra pilaris associated with hypogammaglobulinaemia and furunculosis.
The British journal of dermatology 1994;131(5):717-9.
1994: J Castanet; Jean-Philippe Lacour; J G Fuzibet; Christophe Perrin; S Rodot; Jean-Paul Ortonne
Adult Still's disease associated with hepatitis C virus infection.
Journal of the American Academy of Dermatology 1994;31(5 Pt 1):807-8.
1994: C Baudoin; C Miquel; Laurent Gagnoux-Palacios; L Pulkkinen; Angela M Christiano; J Uitto; G Tadini; Jean-Paul Ortonne; Guerrino Meneguzzi
A novel homozygous nonsense mutation in the LAMC2 gene in patients with the Herlitz junctional epidermolysis bullosa.
Human molecular genetics 1994;3(10):1909-10.
1994: J Castanet; Jean-Philippe Lacour; Christophe Perrin; J F Guidoni; Jean-Paul Ortonne
Sclerodermatous changes revealing porphyria cutanea tarda.
Acta dermato-venereologica 1994;74(4):310-1.
1994: Daniel Aberdam; A Aguzzi; C Baudoin; M F Galliano; Jean-Paul Ortonne; Guerrino Meneguzzi
Developmental expression of nicein adhesion protein (laminin-5) subunits suggests multiple morphogenic roles.
Cell adhesion and communication 1994;2(2):115-29.
1994: Daniel Aberdam; M F Galliano; M G Mattei; Jean-Paul Ortonne; Guerrino Meneguzzi
S-laminin gene (Lams) maps to F1 band of mouse chromosome 9.
Mammalian genome : official journal of the International Mammalian Genome Society 1994;5(6):393-4.
1994: J Vailly; P Szepetowski; M G Mattei; F Pedeutour; Robert E Burgeson; Jean-Paul Ortonne; Guerrino Meneguzzi
The genes for nicein/kalinin 125- and 100-kDa subunits, candidates for junctional epidermolysis bullosa, map to chromosomes 1q32 and 1q25-q31.
Genomics 1994;21(1):286-8.
1994: C Roméro; Edith Aberdam; C Larnier; Jean-Paul Ortonne
Retinoic acid as modulator of UVB-induced melanocyte differentiation. Involvement of the melanogenic enzymes expression.
Journal of cell science 1994;107 ( Pt 4)():1095-103.
1994: Daniel Aberdam; M F Galliano; M G Mattei; A Pisani-Spadafora; Jean-Paul Ortonne; Guerrino Meneguzzi
Assignment of mouse nicein genes to chromosomes 1 and 18.
Mammalian genome : official journal of the International Mammalian Genome Society 1994;5(4):229-33.
1994: Daniel Aberdam; M F Galliano; J Vailly; L Pulkkinen; Jeannette Bonifas; Angela M Christiano; K Tryggvason; J Uitto; E H Epstein; Jean-Paul Ortonne
Herlitz's junctional epidermolysis bullosa is linked to mutations in the gene (LAMC2) for the gamma 2 subunit of nicein/kalinin (LAMININ-5).
Nature genetics 1994;6(3):299-304.
1994: C Baudoin; C Miquel; C Blanchet-Bardon; C Gambini; Guerrino Meneguzzi; Jean-Paul Ortonne
Herlitz junctional epidermolysis bullosa keratinocytes display heterogeneous defects of nicein/kalinin gene expression.
The Journal of clinical investigation 1994;93(2):862-9.
1994: J Vailly; P Verrando; Marie-France Champliaud; D Gerecke; D W Wagman; C Baudoin; Daniel Aberdam; R Burgeson; E Bauer; Jean-Paul Ortonne
The 100-kDa chain of nicein/kalinin is a laminin B2 chain variant.
European journal of biochemistry / FEBS 1994;219(1-2):209-18.
1994: J Castanet; Jean-Philippe Lacour; Christophe Perrin; B Taillan; D Dubois; Jean-Paul Ortonne
Association of eosinophilic fasciitis, multiple morphea and antiphospholipid antibody.
Dermatology (Basel, Switzerland) 1994;189(3):304-7.
1994: J Castanet; S Carmignani; Jean-Philippe Lacour; Christophe Perrin; B Lagrange; J F Dor; Jean-Paul Ortonne
[Pustular vasculitis disclosing Behçet disease].
Annales de dermatologie et de vénéréologie 1994;121(9):629-31.
1994: S Rodot; Jean-Philippe Lacour; C Dageville; J Castanet; P Boutté; Jean-Paul Ortonne
["Bronze baby" syndrome].
Annales de dermatologie et de vénéréologie 1994;121(8):568-70.
1994: I Costa; J Castanet; B Taillan; Jean-Philippe Lacour; Christophe Perrin; Maurice Chazal; V Mondain; Jean-Paul Ortonne
[Aseptic adenitis in pyoderma gangrenosum].
Annales de dermatologie et de vénéréologie 1994;121(8):550-2.
1993: Edith Aberdam; C Roméro; Jean-Paul Ortonne
Repeated UVB irradiations do not have the same potential to promote stimulation of melanogenesis in cultured normal human melanocytes.
Journal of cell science 1993;106 ( Pt 4)():1015-22.
1993: P Verrando; O Schofield; A Ishida-Yamamoto; Daniel Aberdam; O Partouche; Robin A J Eady; Jean-Paul Ortonne
Nicein (BM-600) in junctional epidermolysis bullosa: polyclonal antibodies provide new clues for pathogenic role.
The Journal of investigative dermatology 1993;101(5):738-43.
1993: I Bodokh; Jean-Philippe Lacour; C Rainero; J Castanet; J F Michiels; Jean-Paul Ortonne
[Efficacy of thalidomide against esophageal ulceration in HIV infection].
Presse médicale (Paris, France : 1983) 1993;22(26):1233.
1993: M Rosdy; A Pisani; Jean-Paul Ortonne
Production of basement membrane components by a reconstructed epidermis cultured in the absence of serum and dermal factors.
The British journal of dermatology 1993;129(3):227-34.
1993: J Castanet; Jean-Philippe Lacour; G Garnier; Christophe Perrin; B Taillan; J G Fuzibet; Jean-Paul Ortonne
Neutrophilic dermatosis associated with chronic neutrophilic leukemia.
Journal of the American Academy of Dermatology 1993;29(2 Pt 2):290-2.
1993: Jean-Philippe Lacour; J Castanet; Christophe Perrin; Jean-Paul Ortonne
Follicular mycosis fungoides. A clinical and histologic variant of cutaneous T-cell lymphoma: report of two cases.
Journal of the American Academy of Dermatology 1993;29(2 Pt 2):330-4.
1993: Jean-Paul Ortonne; G Prota
Hair melanins and hair color: ultrastructural and biochemical aspects.
The Journal of investigative dermatology 1993;101(1 Suppl):82S-89S.
1993: C Baudoin; Guerrino Meneguzzi; M M Portier; M Demarchez; F Bernerd; A Pisani; Jean-Paul Ortonne
Peripherin, a neuronal intermediate protein, is stably expressed by neuroendocrine carcinomas of the skin, their xenograft on nude mice, and the corresponding primary cultures.
Cancer research 1993;53(5):1175-81.
1993: Jean-Philippe Lacour; I Bodokh; J Castanet; S Bekri; Jean-Paul Ortonne
Porphyria cutanea tarda and antibodies to hepatitis C virus.
The British journal of dermatology 1993;128(2):121-3.
1993: I Bodokh; Jean-Philippe Lacour; C Rainero; G Orth; Christophe Perrin; P Hoffman; J Santini; Jean-Paul Ortonne
[Focal epithelial hyperplasia. An unusual clinical aspect].
Annales de dermatologie et de vénéréologie 1993;120(8):555-7.
1993: I Bodokh; Jean-Philippe Lacour; Christophe Perrin; Eric Rosenthal; G Garnier; A Pesce; Jean-Paul Ortonne
[Erythroderma disclosing transformation of refractory anemia with excess of blasts into lymphoblastic leukemia].
Annales de dermatologie et de vénéréologie 1993;120(4):303-4.
1993: I Bodokh; Jean-Philippe Lacour; Christophe Perrin; C Rainero; E Lebreton; E Grosshan; Jean-Paul Ortonne
[Cutaneous malacoplakia associated with chronic hepatitis caused by hepatitis C virus].
Annales de dermatologie et de vénéréologie 1993;120(11):808-10.
1993: I Bodokh; Jean-Philippe Lacour; Christophe Perrin; E Ferrari; M Ticchioni; C Roule; C Isetta; J Jourdan; Jean-Paul Ortonne
[Cutaneous leukocytoclastic vasculitis with circulating anticoagulant disclosing myxoma of the left atrium].
Annales de dermatologie et de vénéréologie 1993;120(11):789-92.
1993: V Gallais; Jean-Philippe Lacour; Christophe Perrin; B Halioua; Jean-Paul Ortonne
[Halo eczema around a histiocytofibroma: the Meyerson phenomenon].
Annales de dermatologie et de vénéréologie 1993;120(9):617-20.
1992: Guerrino Meneguzzi; M Peter Marinkovich; Daniel Aberdam; A Pisani; Robert E Burgeson; Jean-Paul Ortonne
Kalinin is abnormally expressed in epithelial basement membranes of Herlitz's junctional epidermolysis bullosa patients.
Experimental dermatology 1992;1(5):221-9.
1992: I Bodokh; Jean-Philippe Lacour; Christophe Perrin; Eric Rosenthal; D Dubois; V Gallais; J P Cassuto; Jean-Paul Ortonne
[Bacillary epithelioid angiomatosis in AIDS. Two cases].
Presse médicale (Paris, France : 1983) 1992;21(34):1616-8, 1623-4.
1992: Jean-Philippe Lacour; A Vitetta; R Chiquet-Ehrismann; A Pisani; Jean-Paul Ortonne
Increased expression of tenascin in the dermis in scleroderma.
The British journal of dermatology 1992;127(4):328-34.
1992: J P Lacour; Jean-Paul Ortonne
[Oculocutaneous albinism].
Annales de pédiatrie 1992;39(7):409-18.
1992: Jean-Paul Ortonne
Retinoic acid and pigment cells: a review of in-vitro and in-vivo studies.
The British journal of dermatology 1992;127 Suppl 41():43-7.
1992: J Castanet; Jean-Philippe Lacour; Christophe Perrin; I Bodokh; J F Dor; Jean-Paul Ortonne
Escherichia coli cellulitis: two cases.
Acta dermato-venereologica 1992;72(4):310-1.
1992: P Verrando; O Partouche; A Pisani; Jean-Paul Ortonne
The 6/2 (AA3) polyclonal antibody identifying a 37 kD keratinocyte protein reacts also with BM-600/nicein, the basement membrane component bound by the monoclonal antibody GB3.
Experimental dermatology 1992;1(1):52-8.
1992: I Bodokh; Jean-Philippe Lacour; Christophe Perrin; V Gallais; Jean-Paul Ortonne
[Hazards of treatment of psoriasis with sulfasalozine].
Presse médicale (Paris, France : 1983) 1992;21(13):630-1.
1992: V Gallais; Jean-Philippe Lacour; Christophe Perrin; G Ghanem; I Bodokh; Jean-Paul Ortonne
Acral hyperpigmented macules and longitudinal melanonychia in AIDS patients.
The British journal of dermatology 1992;126(4):387-91.
1992: Jean-Philippe Lacour; A Vitetta; Jean-Paul Ortonne
Linear IgA dermatosis and thyroid carcinoma.
Journal of the American Academy of Dermatology 1992;26(2 Pt 1):257-9.
1992: J Castanet; Jean-Philippe Lacour; B Taillan; Christophe Perrin; J G Fuzibet; Jean-Paul Ortonne
[Mycosis fungoides during B-cell lymphoma].
Annales de dermatologie et de vénéréologie 1992;119(3):205-8.
1992: F Klein-Lerousseau; Jean-Philippe Lacour; Christophe Perrin; G Bozetto; Jean-Paul Ortonne
["Vanishing" finger pads syndrome: localized acquired cutis laxa?].
Annales de dermatologie et de vénéréologie 1992;119(11):939-41.
1992: Jean-Philippe Lacour; Christophe Perrin; P Thomas; G Nicaise; Carlos Martinot; Jean-Paul Ortonne
[Cutaneous complications after sleep electroencephalography].
Annales de dermatologie et de vénéréologie 1992;119(11):915-9.
1992: V Gallais; Jean-Philippe Lacour; Jean-Paul Ortonne
[Cutaneous pigmentation disorders in human immunodeficiency virus infection].
Annales de dermatologie et de vénéréologie 1992;119(6-7):471-8.
1991: Jean-Philippe Lacour; D Dubois; A Pisani; Jean-Paul Ortonne
Anatomical mapping of Merkel cells in normal human adult epidermis.
The British journal of dermatology 1991;125(6):535-42.
1991: Françoise Bernerd; M Démarchez; Jean-Paul Ortonne; Janusz Czernielewski
Sequence of morphological events during topical application of retinoic acid on the rhino mouse skin.
The British journal of dermatology 1991;125(5):419-25.
1991: Jean-Philippe Lacour; V Gallais; I Bodokh; G Ghanem; Jean-Paul Ortonne
[Cutaneous and mucous hyperpigmentation in AIDS].
Presse médicale (Paris, France : 1983) 1991;20(34):1686, 1690.
1991: Françoise Bernerd; Jean-Paul Ortonne; M Bouclier; A Chatelus; C Hensby
The rhino mouse model: the effects of topically applied all-trans retinoic acid and CD271 on the fine structure of the epidermis and utricle wall of pseudocomedones.
Archives of dermatological research 1991;283(2):100-7.
1991: P Verrando; C Blanchet-Bardon; A Pisani; L Thomas; F Cambazard; Robin A J Eady; O Schofield; Jean-Paul Ortonne
Monoclonal antibody GB3 defines a widespread defect of several basement membranes and a keratinocyte dysfunction in patients with lethal junctional epidermolysis bullosa.
Laboratory investigation; a journal of technical methods and pathology 1991;64(1):85-92.
1991: I Bodokh; Jean-Philippe Lacour; E Nonis; P Boutte; Jean-Paul Ortonne
[Acrodermatitis enteropathica aspect caused by group B vitamin deficiency].
Annales de dermatologie et de vénéréologie 1991;118(11):806-10.
1990: O M Schofield; Jo-David Fine; P Verrando; A H Heagerty; Jean-Paul Ortonne; Robin A J Eady
GB3 monoclonal antibody for the diagnosis of junctional epidermolysis bullosa: results of a multicenter study.
Journal of the American Academy of Dermatology 1990;23(6 Pt 1):1078-83.
1990: O M Schofield; J N McDonald; D Fredj-Reygrobellet; B L Hsi; C J Yeh; Jean-Paul Ortonne; Robin A J Eady
Common antigen expression between human periderm and other tissues identified by GB1-monoclonal antibody.
Archives of dermatological research 1990;282(3):143-8.
1990: M Regnier; Jean-Paul Ortonne; M Darmon
Histological defects of chronic benign familial pemphigus expressed in tissue culture.
Archives of dermatological research 1990;281(8):538-40.
1990: J Castanet; Jean-Philippe Lacour; Jean-Paul Ortonne
[Atypical clinical forms of bullous pemphigoid].
Annales de dermatologie et de vénéréologie 1990;117(1):73-82.
1990: Jean-Philippe Lacour; Jean-Paul Ortonne
[Myalgia-hypereosinophilia syndrome caused by L-tryptophan].
Annales de dermatologie et de vénéréologie 1990;117(12):991-8.
1989: Jean-Philippe Lacour; Christophe Perrin; P Hoffman; A Thyss; H Duplay; Jean-Paul Ortonne
[Congenital diffuse melanosis, lentiginosis, diffuse ganglioneuromatosis and multiple schwannoma of the digestive system: an original neurocristopathy?].
Annales de dermatologie et de vénéréologie 1989;116(11):783-5.
1989: Jean-Philippe Lacour; L Juhlin; P el Baze; H Duplay; Jean-Paul Ortonne
Hyperpigmented acral papular mucinosis, systemic lupus erythematosus and universal alopecia.
Acta dermato-venereologica 1989;69(3):212-6.
1988: P Verrando; A Pisani; Jean-Paul Ortonne
The new basement membrane antigen recognized by the monoclonal antibody GB3 is a large size glycoprotein: modulation of its expression by retinoic acid.
Biochimica et biophysica acta 1988;942(1):45-56.
1988: Janusz Czernielewski; I Masouye; A Pisani; J Ferracin; D Auvolat; Jean-Paul Ortonne
Effect of chronic sun exposure on human Langerhans cell densities.
Photo-dermatology 1988;5(3):116-20.
1988: Jean-Paul Ortonne
Piebaldism, Waardenburg's syndrome, and related disorders. "Neural crest depigmentation syndromes"?
Dermatologic clinics 1988;6(2):205-16.
1988: Christophe Perrin; Jean-Philippe Lacour; A Thyss; J F Michiels; G Rostain; J Valla; Jean-Paul Ortonne
[Subcutaneous rhabdomyosarcoma in children. Clinical, immunologic and ultrastructural aspects].
Annales de dermatologie et de vénéréologie 1988;115(9):919-25.
1988: Jean-Paul Ortonne; J P Petchot-Bacque; P Verrando; A Pisani; G Pautrat; Françoise Bernerd
Normal Merkel cells express a synaptophysin-like immunoreactivity.
Dermatologica 1988;177(1):1-10.
1988: B Halioua; Jean-Paul Ortonne
[Cutaneous neuroendocrine carcinoma].
Annales de dermatologie et de vénéréologie 1988;115(12):1305-22.
1988: Jean-Philippe Lacour; Jean-Paul Ortonne
[Biomaterials and dressings].
Annales de dermatologie et de vénéréologie 1988;115(12):1301-4.
1987: A H Heagerty; Robin A J Eady; A R Kennedy; K H Nicolaides; C H Rodeck; B L Hsi; Jean-Paul Ortonne
Rapid prenatal diagnosis of epidermolysis bullosa letalis using GB3 monoclonal antibody.
The British journal of dermatology 1987;117(3):271-5.
1987: Jean-Paul Ortonne; B L Hsi; P Verrando; Françoise Bernerd; G Pautrat; A Pisani; C J Yeh
Herpes gestationis factor reacts with the amniotic epithelial basement membrane.
The British journal of dermatology 1987;117(2):147-54.
1987: P Verrando; B L Hsi; C J Yeh; A Pisani; N Serieys; Jean-Paul Ortonne
Monoclonal antibody GB3, a new probe for the study of human basement membranes and hemidesmosomes.
Experimental cell research 1987;170(1):116-28.
1987: G Pautrat; Françoise Bernerd; G Morel; Jean-Paul Ortonne; C Hensby
Ultrastructural aspects of skin after cryoultramicrotomy.
Acta dermato-venereologica 1987;67(5):377-84.
1986: P Verrando; Jean-Paul Ortonne; G Pautrat; B L Hsi; C J Yeh
Identification of a 37 kilodalton protein at the epidermal basement membrane by an antiserum to human amnion.
The Journal of investigative dermatology 1986;87(2):190-6.
1986: A H Heagerty; A R Kennedy; Robin A J Eady; B L Hsi; P Verrando; C J Yeh; Jean-Paul Ortonne
GB3 monoclonal antibody for diagnosis of junctional epidermolysis bullosa.
Lancet 1986;1(8485):860.
1985: A R Kennedy; A H Heagerty; Jean-Paul Ortonne; B L Hsi; C J Yeh; Robin A J Eady
Abnormal binding of an anti-amnion antibody to epidermal basement membrane provides a novel diagnostic probe for junctional epidermolysis bullosa.
The British journal of dermatology 1985;113(6):651-9.
1983: G Illy; H Duplay; P El Baze; M Baréty; Jean-Paul Ortonne
[Cutaneous neuroendocrine carcinoma : apropos of a case].
Annales de dermatologie et de vénéréologie 1983;110(6-7):525-35.
1983: G Illy; P El Baze; Jean-Paul Ortonne
[Merkel's cell : current data].
Annales de dermatologie et de vénéréologie 1983;110(6-7):555-61.